Shandong Sito Bio-technology Co., Ltd. (300583.SZ)

25.09 -0.12 (-0.48%) At close: 03:04PM CST

Shandong Sito Bio-technology Co., Ltd.

Renxin industrial park
Dingtao district
Heze
China
86 53 0226 3536
https://www.sitobiotech.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 1,140

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Qi Mi	Chairman & GM	N/A	N/A	1990
Mr. Fuwen Li	Chief Financial Officer	N/A	N/A	1976
Ms. Qing Zhi Kong	Deputy Gen. Mang.	N/A	N/A	1971
Qingli Zeng	Securities Representative	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Shandong Sito Bio-technology Co., Ltd. researches and develops new steroid hormones, intermediates, and derivatives. Its products include 9a-hydroxyandrostenedione, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, dexamethasone epoxy hydrolysate, progesterone intermediate, opener, tetraene, androstenedione, ketal, acid removal, 3-ketal, and betamethasone epoxy hydrolyzate, as well as 1,4-androstenedione. The company was founded in 2002 and is based in Heze, China.

Corporate Governance

Shandong Sito Bio-technology Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.